An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer

Uro-Oncology

Emerging Immunotherapy Options for BCG-unresponsive Non-muscle-invasive Bladder Cancer

J Urol.

Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC

doi: 10.1097/JU.0000000000000297.

Pregnancy and Childbirth

Association of Gestational Weight Gain and Maternal Body Mass Index in Early Pregnancy With Risk for Nonaffective Psychosis in Offspring

JAMA Psychiatry.

Mackay E, Dalman C, Karlsson H, Gardner RM

doi: 10.1001/

Uro-Oncology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

Eur Urol.

Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V

doi: 10.1016/j.eururo.2019.08.016.

Uro-Oncology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Eur Urol

Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ

doi: 10.1016/j.eururo.2021.08.010

Urinary Incontinence

Urinary Incontinence and Nocturia in Older Men: Associations with Body Mass, Composition, and Strength in the Health, Aging, and Body Composition Study

J Urol.

Bauer SR, Grimes B, Suskind AM, Cawthon PM, Cummings S, Huang AJ, Health ABC Study.

doi: 10.1097/JU.

Overactive BladderUro-Oncology

Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients

Clin Genitourin Cancer.

Moschini M, Shariat SF, Lucianò R, D'Andrea D, Foerster B, Abufaraj M, Bandini M, Dell'Oglio P, Damiano R, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A

doi: 10.1016/j.clgc.2016.12.006.

Overactive BladderUro-Oncology

High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer

Int J Urol.

Tan YG, Eu EWC, Huang HH, Lau WKO

doi: 10.1111/iju.13480.

Overactive BladderUro-Oncology

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

Clin Genitourin Cancer.

Pagliarulo V, Ancona P, Petitti T, Salerno A, Spadavecchia R, Di Stasi S, Cormio L, Maurizio B, Carrieri G, Ditonno P

doi: 10.1016/j.clgc.2016.11.005.

Uro-Oncology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Eur Urol.

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimäe E, Ribal MJ, van der Heijden AG

doi: 10.1016/j.eururo.2020.03.055.

Related content

Emerging Immunotherapy Options for BCG-unresponsive Non-muscle-invasive Bladder Cancer

Association of Gestational Weight Gain and Maternal Body Mass Index in Early Pregnancy With Risk for Nonaffective Psychosis in Offspring

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Urinary Incontinence and Nocturia in Older Men: Associations with Body Mass, Composition, and Strength in the Health, Aging, and Body Composition Study

Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients

High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines